Health knowledge and news provided by doctors.

Ads by Google

Prescription Drugs

FDA Considers Additional Test Results When Assessing New Drug Safety

In the first use of a framework allowing submission of a single application to the two agencies, FDA and EMEA worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs.

Health and Wellness: 

ETHEX Recalls Morphine Tablets

ETHEX Corporation has voluntarily recalled a single lot of morphine sulfate 60 mg extended release tablets (Lot No. 91762) due to a report of a tablet with twice the appropriate thickness.

Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The lot was distributed by ETHEX Corporation under an "ETHEX" label between April 16th and April 27th of 2008. No other dosage strength, nor any other lot of the 60 mg strength is affected by this recall.

Health and Wellness: 

Diabetes Drugs Emerge As Top Force In Drug Spending

Diabetes treatments are now the leading driver of prescription drug spending growth, displacing lipid-lowering drugs which fell precipitously after a decade of reigning in the top position, as generic drugs cut the cost of treating high cholesterol. These new findings were reported by Medco Health Solutions Inc., the nation's leading pharmacy benefit manager, in its just-released 2008 Drug Trend Report, a comprehensive analysis of prescription drug spending and utilization.

Health and Wellness: 

Common Drug Eases Leg Cramping

People with leg cramps caused by narrowing blood vessels often stop walking because of the pain. In fact, some say they have "shop window disease," because they pretend to gaze into store windows during the embarrassing pauses. But those who take naftidrofuryl -- a drug that relaxes blood vessels -- don't have to pause nearly as often, according to a new review by Belgian researchers.

Health and Wellness: 

Massachusetts Coalition Wants Controls on Drug Marketing

A coalition of Massachusetts community organizations, nonprofits, insurers, and health care providers is asking the state government to regulate the marketing practices of pharmaceutical companies, claiming it will help ensure more affordable prescription drugs for everyone.

Health and Wellness: